Compare Merck & Co., Inc. (MRK) vs Pinterest Inc (PINS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merck & Co., Inc. vs Pinterest Inc — how do they compare? Merck & Co., Inc. trades at $125.97 (market cap $307.25B), while Pinterest Inc trades at $22.65 (market cap $12.78B). The key difference: Merck & Co., Inc. is far larger — about 24× Pinterest Inc's market cap, and Merck & Co., Inc. pays a 2.73% dividend while Pinterest Inc pays none. Which is the better fit depends on your goals.
| MRK | PINS | |
|---|---|---|
Market Cap | $307.25B | $12.78B |
Sector | Health | Media |
52-Week High | $129.52 | $39.17 |
52-Week Low | $77.60 | $15.42 |
Enterprise Value | $350.66B | $12.68B |
Dividend Yield | 2.73% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Merck (MRK) trades at $126.27, down 0.96% on the day, with a neutral technical signal and strong fundamental performance. The company reported robust 2025 results with $65.01B revenue and $18.25B net income, beating EPS estimates in recent quarters. Recent news highlights Merck's acquisition of Terns Pharmaceuticals to bolster its oncology pipeline, while analyst consensus remains bullish with a $137.30 price target.
Outlook is positive driven by earnings momentum and strategic M&A, but risks include patent expirations and competitive pressures. The stock offers a dividend yield with upcoming payment, supporting income investors. Valuation multiples are elevated, requiring sustained growth to justify current levels amid macroeconomic uncertainties.
Pinterest (PINS) trades at $22.835, down 1.57% on the day, with a bullish technical outlook driven by moving averages and a consensus analyst price target of $27.53. Revenue grew to $4.22B in 2025, with net income turning positive at $416.86M, though Q2 2026 earnings are pending. Recent news highlights focus on user growth and e-commerce integration, while insider sales and cash flow trends warrant monitoring.
The stock presents upside potential from strong analyst buy ratings and revenue expansion, but risks include negative net cash flow, high valuation multiples, and competitive pressures in social media. Investor sentiment is cautiously optimistic ahead of Q2 earnings, with institutional activity showing mixed signals.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →About Pinterest Inc
Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →
